期刊文献+

老年急性冠脉综合征患者胰岛素抵抗与冠状动脉钙化积分及预后的关系 被引量:2

Correlation of insulin resistance with coronary calcium score and prognosis in elderly patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨老年非ST段抬高型急性冠脉综合征(ACS)患者胰岛素抵抗(IR)与冠状动脉钙化严重程度的关系及对患者临床预后的影响。方法入选2013年6月至2014年6月广州市第一人民医院心内科收治的非ST段抬高型ACS的老年患者(年龄/〉60岁)150例。采用稳态模型方法(HOMA)计算IR指数(HOMA—IR),并根据HOMA-IR,将所有患者分为两组:IR组(HOMA—IR〉5.0;n=80)和非IR组(HOMA-IR≤5.0;n=70)。入选患者行经皮冠状动脉介入治疗(PCI)前均接受螺旋CT心脏冠脉成像检查,计算冠状动脉钙化积分(CCS)。PCI术后对两组患者进行12个月的随访,记录主要心脏不良事件(MACE)的发生情况。结果两组患者的空腹血糖、空腹胰岛素、低密度脂蛋白胆固醇(LDL—C)、高敏C-反应蛋白(hs—CRP)和同型半胱氨酸(Hcy)间均具有显著性差异(P〈0.05)。Spearman相关分析显示老年ACS患者HOMA—IR和CCS呈正相关(r=0.393,P〈0.01)。随访12个月,多因素logistic回归分析显示HOMA—IR〉5.0,CCS〉400、纽约心脏病协会(NYHA)分级Ⅲ-Ⅳ级和糖尿病是老年ACS患者PCI术后MACE发生的独立危险因素;Kaplan-Meier生存分析显示IR组患者累积生存率显著低于非IR组(Log-rank=4.755,P=0.029)。结论存在IR的老年非ST段抬高型ACS患者冠状动脉钙化更为严重,IR及CCS对接受PCI术的老年非ST段抬高型ACS患者临床预后有预测价值。 Objective To investigate the relationship of insulin resistance (IR) with the severity of coronary calcification and determine the effect of IR on prognosis in the elderly patients with non-ST segment elevation acute coronary syndrome (NSTACS). Methods A total of 150 consecutive elderly patients ( I〉60 years old) with NSTACS admitted in our department from June 2013 to June 2014 were enrolled in this study. Based on their IR index measured by homeostasis model assessment ( HOMA), they were divided into the IR group ( HOMA-IR 〉 5.0, n = 80) and non-IR group ( HOMA-IR ≤ 5.0, n = 70). All patients received 320-detector row computed tomography scanning to calculate coronary calcium score (CCS) before percutaneous coronary intervention (PCI). These patients were followed up for 12 months, and the occurrence of major adverse cardiac events (MACE) were recorded. Results The levels of fasting plasma glucose ( FPG), fasting insulin ( FINS ), low density lipoprotein-cholesterol ( LDL-C ), high sensitivity C-reactive protein (hs-CRP) and homocysteine (Hcy) had significant discrepancies between the patients of IR and non-IR groups (P 〈0.05). Spearman correlation analysis showed that HOMA-IR was positively correlated with CCS in the elderly NSTACS patients ( r = 0. 393, P 〈 0. 01 ). In 12 months of follow-up, muhivariate logistic regression analysis showed that HOMA-IR 〉 5.0, CCS 〉 400, New York Heart Association (NYHA) classification grade Ⅲ - Ⅳ and diabetes were independent risk factors for MACE in the elderly NSTACS patients after PC[ (P 〈 0.05 ). Kaplan-Meier survival analysis indicated that the cumulative survival rates was significantly lower in the IR group than in the non-IR group ( Log rank = 4. 755, P = 0. 029). Conclusion The elderly ACS patients with IR have more serious coronary calcification. IR and CCS are of predictive value for the prognosis in the elderly NSTACS patients undergoing PCI.
出处 《中华老年多器官疾病杂志》 2016年第8期601-604,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
基金 广州市科技计划项目民生科技重大专项(2012Y2-00025)~~
关键词 胰岛素抵抗 冠状动脉疾病 钙质沉着症 insulin resistance coronary disease caleinosis
  • 相关文献

参考文献13

  • 1Opar SP, Short MW, Jorgensen JE, et al. Acute coronary syndrome and cardiac arrest: using simulation to assess resident performance and program outcomes[ J]. J Grad Med Educ, 2010, 2(3) : 404 -409.
  • 2Wilson SR, Lin FY, Min JK. Role of coronary artery calcium score and coronary CT angiography in the diagnosis and risk stratification of individuals with suspected coronary artery disease [ J ]. Cun" Cardiol Rep, 2011, 13(4) : 271 -279.
  • 3Kannan L, Chemoff A. Insulin resistance and atherosclerosis: is it time to measure HOMA-IR to predict coronary artery disease[ J] ? N Am J Med Sci, 2013, 5(10) : 615 -616.
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2143
  • 5Genders TS, Pugliese F, Mollet NR, et al. Incremental value of the CT coronary calcium score for the prediction of coronary artery disease[J]. Eur Radiol, 2010, 20(10) : 2331 -2340.
  • 6Srinivasan MP, Kamath PK, Manjrekax PA, et al. Correlation of severity of coronary artery disease with insulin resistance[ J]. N Am J Med Sci, 2013, 5(10): 611 -614.
  • 7Peix A, Cabrera LO, Rodriguez L, et al. Cardiac outcomes 3 years after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: value of myocardial perfusion imaging and coronary calcium score [ J]. Nucl Med Commun, 2015, 36 (2) : 156 - 161.
  • 8Blaha MJ, DeFilippis AP, Rivera JJ, et al. The relationship between insulin rsistance and incidence and progression of coronary artery calcification : the Multi-Ethnic Study of Atheosclerosis [ J ]. Diabetes Care, 2011, 34(3): 749-751.
  • 9Madhavan MV, Tarigopula M, Mintz GS, et al. Coronary artery calcification: pathogenesis and prognostic implication [ J ]. J Am Coil Cardiol, 2014, 63( 17): 1703-1714.
  • 10Panayiotou AG, Kouis P, Griffin M, et al. Comparison between insulin resistance indices and carotid and femoral atherosclerosis: a cross-sectionnal population study [ J ]. Int Angiol, 2015, 34 (5) : 437 - 444.

二级参考文献24

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.

共引文献2142

同被引文献6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部